Recent Updates
Recently added Catalysts
ABBV Positive Sentiment

AbbVie to Host Third-Quarter 2026 Earnings Conference Call

Thursday, October 1, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: AbbVie will announce its third-quarter 2026 financial results on October 30, 2026, before market opening. A live webcast of the earnings conference call will take place at 8 a.m. Central time, accessible via AbbVie's Investor Relations website. An archived version will be available later that day.

Market Sentiment Analysis

POSITIVE FACTORS

  • AbbVie is set to announce its financial results, indicating ongoing business activity.
  • The earnings call provides transparency to investors and stakeholders.
  • The company continues to focus on innovative medicines and solutions.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+33%
120-day peak, hindsight
Typical move
1.5%
average across 15 past catalysts
Lead asset
ABBV-706
Phase 3 · Small Cell Lung Cancer

Full Press Release Details

NORTH CHICAGO, Ill., Oct. 1, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its third-quarter 2026 financial results on Friday, October 30, 2026, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time. It will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.
Media: Cat Langel (708) 508-3524 [email protected] Investors: Liz Shea (847) 935-2211 [email protected]

Investors:

Liz Shea (847) 935-2211
[email protected]

Frequently Asked Questions

When will AbbVie announce its Q3 2026 financial results?

AbbVie will announce its Q3 2026 financial results on October 30, 2026.

What time is the AbbVie earnings conference call?

The earnings conference call will be held at 8 a.m. Central time.

Where can I access the AbbVie earnings call webcast?

The webcast will be accessible through AbbVie's Investor Relations website.

Will there be an archive of the earnings call?

Yes, an archived edition of the session will be available later that day.

ShareAdd on Google
Tags: ABBV AbbVie earnings call financial results Q3 2026 investor relations
Last updated: Oct 1, 2026

Biotech snapshot

Cash runway
$6569M liquidity · $0M/mo burn
Low dilution risk
Lead asset
ABBV-706Phase 3
Small Cell Lung Cancer →

Catalyst track record

+33%
best trade around ABBV's most recent catalyst

Peak hindsight return over a 120-day window, across 15 tracked FDA/PDUFA catalysts for ABBV.

See every catalyst's timing & PoA →